Blog

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

Rahul Banerjee/X

Aug 10, 2024, 12:42

Rahul Banerjee: MajesTEC-1 analysis of response predictors in Multiple Myeloma by Cortes-Selva

Rahul Banerjee, Assistant Professor at University of Washington, shared a post on X:

“EXCELLENT Blood Journal MajesTEC-1 analysis of response predictors in MMsm (Cortes-Selva et al).

Article focuses on T cells, mehh – I’ll focus on fascinating BCMA facts instead.

BCMA on BMPCs (flow) does NOT predict ORR.
Lower sBCMA is better.”

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

Authors: Diana Cortes-Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, Onsay Lau, Karl Calara-Nielsen, Cuc Davis, Jaymala Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S Wu, Philippe Moreau, Saad Z Usmani, Nizar J Bahlis, Niels W C J van de Donk, and Raluca I Verona.

For more information.

Source: Rahul Banerjee/X

Blood Journal cancer Diana Cortes-Selva MajesTEC-1 Niels W. C. J. van de Donk Nizar J Bahlis OncoDaily Oncology Rahul Banerjee Raluca I Verona Sheri Skerget Tatiana Perova

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology